ATE178608T1 - Metall-organische kobalt-verbindungen und deren verwendungen - Google Patents

Metall-organische kobalt-verbindungen und deren verwendungen

Info

Publication number
ATE178608T1
ATE178608T1 AT90900578T AT90900578T ATE178608T1 AT E178608 T1 ATE178608 T1 AT E178608T1 AT 90900578 T AT90900578 T AT 90900578T AT 90900578 T AT90900578 T AT 90900578T AT E178608 T1 ATE178608 T1 AT E178608T1
Authority
AT
Austria
Prior art keywords
group
treating
subject
different
alkyl group
Prior art date
Application number
AT90900578T
Other languages
English (en)
Inventor
Zvi Dori
David Gershon
Original Assignee
Redox Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redox Pharma Corp filed Critical Redox Pharma Corp
Application granted granted Critical
Publication of ATE178608T1 publication Critical patent/ATE178608T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/06Cobalt compounds
    • C07F15/065Cobalt compounds without a metal-carbon linkage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemically Coating (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90900578T 1988-12-02 1989-12-04 Metall-organische kobalt-verbindungen und deren verwendungen ATE178608T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/279,417 US5049557A (en) 1986-05-13 1988-12-02 Metallo-organic salt compounds and pharmaceutical uses thereof

Publications (1)

Publication Number Publication Date
ATE178608T1 true ATE178608T1 (de) 1999-04-15

Family

ID=23068878

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90900578T ATE178608T1 (de) 1988-12-02 1989-12-04 Metall-organische kobalt-verbindungen und deren verwendungen

Country Status (9)

Country Link
US (1) US5049557A (de)
EP (1) EP0481994B1 (de)
JP (1) JPH04507398A (de)
AT (1) ATE178608T1 (de)
AU (1) AU637340B2 (de)
CA (1) CA2004534C (de)
DE (1) DE68928968T2 (de)
IL (1) IL92512A (de)
WO (1) WO1990006119A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756491A (en) * 1986-05-13 1998-05-26 Chai-Tech Corporation Antiviral cobalt-organic compounds
US5258403A (en) * 1986-05-13 1993-11-02 Chai-Tech Corporation Metallo-organic salt compounds and pharmaceutical uses thereof
US5106841A (en) * 1986-05-13 1992-04-21 Chai-Tech Corporation Antiviral compositions and method for their use
AU5871494A (en) * 1992-12-15 1994-07-04 Redox Pharmaceutical Corporation Antiviral compositions and method for their use
US6008190A (en) * 1994-12-15 1999-12-28 California Institute Of Technology Cobalt Schiff base compounds
DE69942976D1 (de) * 1998-05-06 2011-01-05 Children S Hospital Res Foundation Verfahren zur hsv-prophylaxe
CA2343824A1 (en) * 1998-06-11 1999-12-16 Redox Pharmaceutical Corporation Method of hiv and hpv prophylaxis
US6376483B1 (en) 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
WO2001005396A1 (en) * 1999-07-16 2001-01-25 The Trustees Of Columbia University In The City Of New York Use of cobalt chelates for treating or preventing virus infection
US6756368B1 (en) 1999-07-16 2004-06-29 The Trustees Of Columbia University In The City Of New York Use of cobalt chelates for treating or preventing virus infection
EP1284726A4 (de) * 2000-03-10 2005-07-20 Childrens Hosp Medical Center Methode zur prophylaktischen behandlung einer chlamydieninfektion
US6780856B2 (en) * 2000-04-07 2004-08-24 California Institute Of Technology Towards increased shelf life for cobalt(III) schiff base complexes
AU2004249292A1 (en) * 2003-06-20 2004-12-29 Redox Pharmaceutical Corporation Microbicidal, prophylactic and therapeutic effect of CTC-96 on papilloma viruses
JP4961700B2 (ja) 2005-09-08 2012-06-27 Jnc株式会社 末端が水素であるナフタレン誘導体、この誘導体を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子
US20100298415A1 (en) * 2009-03-23 2010-11-25 Northwestern University Targeted schiff base complexes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3420865A (en) * 1966-05-12 1969-01-07 Colgate Palmolive Co Novel carbocyclic ferrocenes
DE2527158A1 (de) * 1975-06-18 1976-12-23 Herz Eberhard Arzneimittel zur behandlung von infektionskrankheiten und von nicht nachweisbar durch mikroorganismen ausgeloeste entzuendungen in der human- und veterinaermedizin
CA1218600A (en) * 1982-12-06 1987-03-03 Gerald L. Maurer Methods and compositions for treating inflammation or arthritis
DE3404443A1 (de) * 1984-02-08 1985-08-08 Hartmut Prof. Dr. 1000 Berlin Köpf Metallicenium-salze und deren verwendung als cytostatica bei der krebsbekaempfung
US4514522A (en) * 1984-07-27 1985-04-30 University Patents, Inc. Oxygen sorbent
US4727068A (en) * 1985-10-23 1988-02-23 Johnson Matthey, Inc. Radiosensitization by cobalt and Fe(III) complexes
IL82376A (en) * 1986-05-13 1991-06-10 Chai Tech Corp Pharmaceutical composition for the treatment of inflammatory conditions
US4735634A (en) * 1986-08-28 1988-04-05 Air Products And Chemicals, Inc. Pillared cobalt complexes for oxygen separation
HU198913B (en) * 1987-09-03 1989-12-28 Pliva Pharm & Chem Works Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
US4950790A (en) * 1988-11-14 1990-08-21 Air Products And Chemicals, Inc. Volatile fluorinated β-ketoimines and associated metal complexes
CA2004639A1 (en) * 1988-12-12 1990-06-12 John A. T. Norman Fluorinated beta-ketoimines and beta-ketoiminato metal complexes

Also Published As

Publication number Publication date
CA2004534C (en) 1995-12-26
EP0481994A4 (en) 1993-03-03
US5049557A (en) 1991-09-17
IL92512A0 (en) 1990-08-31
EP0481994A1 (de) 1992-04-29
CA2004534A1 (en) 1990-06-02
AU4748390A (en) 1990-06-26
IL92512A (en) 1998-12-06
EP0481994B1 (de) 1999-04-07
DE68928968D1 (de) 1999-05-12
JPH04507398A (ja) 1992-12-24
WO1990006119A1 (en) 1990-06-14
AU637340B2 (en) 1993-05-27
DE68928968T2 (de) 2000-01-05

Similar Documents

Publication Publication Date Title
ATE178608T1 (de) Metall-organische kobalt-verbindungen und deren verwendungen
IT1178154B (it) Impiego in terapia di composti di trasferimento di metilolo, relative composizioni farmaceutiche e procedimento per preparare queste
CA2045077A1 (en) Anti-epileptics
NO158507C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9-halogen-7-okso-2,3-dihydro-7h-pyrido (1,2,3-de)(1,4)-benzoksazin-6-karboksylsyreforbindelser.
ATE1814T1 (de) 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung.
NO154089C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
DE69330282D1 (de) Chinolon und acridinon derivate zur behandlung der harninkontinenz
IL97729A0 (en) Antiviral compositions and method for their use
DE69312567D1 (de) 2-Formylpyridin-Thiosemicarbazonderivate, ihre Herstellung und ihre Verwendung als Antitumor Mittel
MY115805A (en) Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
IE39679B1 (en) Methods and compositions for killing parasites of warm blooded animals
ES8206537A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina
IL70082A (en) Pharmaceutical compositions comprising 1-aroyl-5-oxo-2-pyrrolidinopropanoic acids and salts and esters thereof,certain such compounds and their preparation
DE3374401D1 (en) 4-hydroxy-alpha-ethyl benzhydroles, process for their preparation and medicines containing these compounds
ES535903A0 (es) Procedimiento de preparacion de derivados de nitrosoureas
SE8104393L (sv) Llalfa-amino-androstaner
HUT59415A (en) Process for producing new benzoheterocyclyl alkylaminoalkane diphosphonic acids and pharmaceutical compositions comprising same as active ingredient
DE3175939D1 (en) Use of gamma-piperidino-butyrophenones for the preparation of medicaments for treating diarrhoea
JPS6452720A (en) Nootropic

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties